State Street’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,197,810
| Closed | -$59.3M | – | 4558 |
|
|
2023
Q3 | $59.3M | Sell |
3,197,810
-982,414
| -24% | -$11.1M | ﹤0.01% | 1522 |
|
|
2023
Q2 | $46.2M | Buy |
4,180,224
+1,125,714
| +37% | +$15.7M | ﹤0.01% | 1719 |
|
|
2023
Q1 | $41M | Sell |
3,054,510
-121,415
| -4% | -$2.1M | ﹤0.01% | 1787 |
|
|
2022
Q4 | $39.3M | Buy |
3,175,925
+124,341
| +4% | +$1.76M | ﹤0.01% | 1799 |
|
|
2022
Q3 | $42.6M | Sell |
3,051,584
-425,048
| -12% | -$6.84M | ﹤0.01% | 1706 |
|
|
2022
Q2 | $48M | Buy |
3,476,632
+254,800
| +8% | +$4.08M | ﹤0.01% | 1667 |
|
|
2022
Q1 | $52.4M | Sell |
3,221,832
-32,434
| -1% | -$508K | ﹤0.01% | 1729 |
|
|
2021
Q4 | $53M | Buy |
3,254,266
+108,825
| +3% | +$1.83M | ﹤0.01% | 1764 |
|
|
2021
Q3 | $46.7M | Buy |
3,145,441
+488,857
| +18% | +$7.82M | ﹤0.01% | 1860 |
|
|
2021
Q2 | $53.1M | Sell |
2,656,584
-178,758
| -6% | -$3.54M | ﹤0.01% | 1799 |
|
|
2021
Q1 | $65.4M | Buy |
2,835,342
+284,592
| +11% | +$7.93M | ﹤0.01% | 1548 |
|
|
2020
Q4 | $63M | Buy |
2,550,750
+860,697
| +51% | +$28.5M | ﹤0.01% | 1493 |
|
|
2020
Q3 | $70.1M | Buy |
1,690,053
+435,702
| +35% | +$20M | ﹤0.01% | 1204 |
|
|
2020
Q2 | $60.1M | Buy |
1,254,351
+98,552
| +9% | +$7.61M | ﹤0.01% | 1322 |
|
|
2020
Q1 | $72.8M | Buy |
1,155,799
+2,668
| +0.2% | +$240K | 0.01% | 1026 |
|
|
2019
Q4 | $143M | Sell |
1,153,131
-307,235
| -21% | -$27.5M | 0.01% | 844 |
|
|
2019
Q3 | $96.9M | Buy |
1,460,366
+216,580
| +17% | +$14.5M | 0.01% | 1016 |
|
|
2019
Q2 | $99M | Buy |
1,243,786
+123,072
| +11% | +$11M | 0.01% | 1046 |
|
|
2019
Q1 | $125M | Buy |
1,120,714
+193,417
| +21% | +$21.1M | 0.01% | 881 |
|
|
2018
Q4 | $93.5M | Sell |
927,297
-83,669
| -8% | -$8.67M | 0.01% | 938 |
|
|
2018
Q3 | $128M | Sell |
1,010,966
-317,443
| -24% | -$33.6M | 0.01% | 915 |
|
|
2018
Q2 | $111M | Sell |
1,328,409
-68,646
| -5% | -$5.03M | 0.01% | 960 |
|
|
2018
Q1 | $85.9M | Buy |
1,397,055
+145,654
| +12% | +$8.78M | 0.01% | 1094 |
|
|
2017
Q4 | $73.1M | Buy |
1,251,401
+351,398
| +39% | +$22.2M | 0.01% | 1203 |
|
|
2017
Q3 | $52.2M | Buy |
900,003
+150,431
| +20% | +$16.2M | ﹤0.01% | 1342 |
|
|
2017
Q2 | $90.7M | Sell |
749,572
-55,978
| -7% | -$6.48M | 0.01% | 1011 |
|
|
2017
Q1 | $91.1M | Buy |
805,550
+54,523
| +7% | +$6.37M | 0.01% | 1006 |
|
|
2016
Q4 | $81.6M | Buy |
751,027
+126,011
| +20% | +$15M | 0.01% | 1016 |
|
|
2016
Q3 | $103M | Buy |
625,016
+104,449
| +20% | +$16.5M | 0.01% | 864 |
|
|
2016
Q2 | $74.3M | Sell |
520,567
-840
| -0.2% | -$122K | 0.01% | 978 |
|
|
2016
Q1 | $67M | Buy |
521,407
+112,431
| +27% | +$13.3M | 0.01% | 1027 |
|
|
2015
Q4 | $61.1M | Buy |
408,976
+91,189
| +29% | +$15.4M | 0.01% | 1068 |
|
|
2015
Q3 | $52.7M | Buy |
317,787
+49,036
| +18% | +$10.8M | 0.01% | 1128 |
|
|
2015
Q2 | $64.9M | Buy |
268,751
+40,288
| +18% | +$10.7M | 0.01% | 1110 |
|
|
2015
Q1 | $64.4M | Sell |
228,463
-36,623
| -14% | -$7.93M | 0.01% | 1095 |
|
|
2014
Q4 | $41.4M | Buy |
265,086
+67,757
| +34% | +$12.5M | ﹤0.01% | 1321 |
|
|
2014
Q3 | $46.7M | Buy |
197,329
+21,412
| +12% | +$5.46M | 0.01% | 1216 |
|
|
2014
Q2 | $41.6M | Buy |
175,917
+9,984
| +6% | +$2.63M | ﹤0.01% | 1318 |
|
|
2014
Q1 | $54.7M | Sell |
165,933
-178,852
| -52% | -$60.4M | 0.01% | 1156 |
|
|
2013
Q4 | $23.5M | Buy |
344,785
+251,295
| +269% | +$14.5M | ﹤0.01% | 1632 |
|
|
2013
Q3 | $6.46M | Buy |
93,490
+32,384
| +53% | +$1.6M | ﹤0.01% | 2376 |
|
|
2013
Q2 | $2.74M | Buy |
+61,106
| New | +$2.09M | ﹤0.01% | 2802 |
|
State Street's ICPT Position: Q4 2023 in Review
State Street sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 3,197,810 shares — an estimated $59.3M sold.
State Street first reported a position in ICPT in Q2 2013 and held it in 42 quarters. The position peaked at $143M in Q4 2019. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- State Street reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- State Street sold 3,197,810 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $59.3M.
- State Street first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 42 quarters.
- State Street's Intercept Pharmaceuticals, Inc. position peaked at $143M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.